scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery
External Resource: Annotation
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| B | RRM_1 | e6ehyB1 | A: a/b three-layered sandwiches | X: SH3 | H: SH3 | T: SH3 | F: RRM_1 | ECOD (v294.1) |
| A | RRM_1 | e6ehyA1 | A: a/b three-layered sandwiches | X: SH3 | H: SH3 | T: SH3 | F: RRM_1 | ECOD (v294.1) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| | scFv ABVANCE | SCFV-HEAVY-KAPPA | Homo sapiens (human) | IGHV1-69*01, IGHV1-69*12, IGHV1-69*13, IGHV1-69D*01, IGHJ4*01, IGHJ4*02, IGHJ4*03, IGKV1-5*03, IGKJ1*01, IGKJ2*01 | V-DOMAIN VH, V-DOMAIN V-KAPPA | IG | SCFV-HEAVY-KAPPA | IMGT (202613-0) |